The Winning Pitch Finalist 1: IVMED-80 Eyedrops for Keratoconus | ASCRS
Presentation
The Winning Pitch Finalist 1: IVMED-80 Eyedrops for Keratoconus
May 2019
Meeting: 2019 Annual Meeting
Session: SYM-207: The Winning Pitch Challenge
Presenter: Bala Ambati, MD, PhD, MBA
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

IVMED-80, a twice-daily eye drop for the treatment of keratoconus, is in development by iVeena Delivery Systems. This drug, with its copperbased formulation, is reportedly the first eye drop designed to treat keratoconus without the need for adjunctive laser treatment or surgical intervention.
View More Presentations from SYM-207

This presentation is from the session "SYM-207: The Winning Pitch Challenge" from the 2019 ASCRS Annual Meeting held on May 4-7, 2019 in San Diego, California.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.